ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1371

Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches

Susan Murphy1, Yen Chen2, Mary Alore2, Sheri Hicks2 and Dinesh Khanna2, 1University of Michigan, Grosse Ile, MI, 2University of Michigan, Ann Arbor, MI

Meeting: ACR Convergence 2021

Keywords: complement, Fatigue, health behaviors, Scleroderma, Systemic sclerosis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 8, 2021

Title: Systemic Sclerosis & Related Disorders – Clinical Poster II (1364–1390)

Session Type: Poster Session C

Session Time: 8:30AM-10:30AM

Background/Purpose: People with systemic sclerosis (SSc) have a high burden of chronic symptoms that have dramatic effects on function and quality of life. Fatigue, along with pain, sleep disturbance, and physical limitations, affects the ability to fulfill life roles. Unfortunately, relevant interventions that can help people with SSc learn skills to manage fatigue and co-occurring symptoms and to improve wellbeing are not currently available in clinical care and are urgently needed. This pilot study examined feasibility and preliminary effects of a web-based intervention called the Resilience-Based Energy Management Program to Enhance Wellbeing (RENEW) intervention.

Methods: Participants with SSc and had access to a reliable, internet-connected device were enrolled. The study design was a one arm, pretest-posttest trial. The intervention involved 12 weeks of working on health goals based on online modules. Trained “peer” health coaches, who also had an SSc diagnosis, assisted in establishing goals and checking on progress during regular calls (10 over the study). We examined feasibility metrics (recruitment/retention rates, and coach call participation), symptom outcomes, patient global impression of change (PGIC), and end-of-program feedback. Outcomes were assessed at baseline, mid-treatment (6 weeks) and 12 weeks, including PROMIS29 and perceived self-efficacy to manage the condition. Participant characteristics and feasibility metrics were analyzed using descriptive statistics. One-way repeated-measures analysis of variance (ANOVA) was used to analyze changes in outcomes over time. SPSS 24.0 was used for analyses, and statistical significance was set at p < 0.05.

Results: Twenty-two participants consented, 21 completed baseline questionnaires; of these, 19 (90%) completed 12-week questionnaires. Participants had a mean age of 54 ± 11 years, (range 25 – 67), 64% were female, and 90% were White (Table 1). Of the 21 participants, 43% had diffuse SSc, 48% had limited SSc, and 9% had overlap. Mean health coach call participation was 9 calls + 1.1. Among completers of the program, 13 (68.4%) rated overall quality of this program as excellent and 6 (31.6%) rated as good. 72% of participants reported moderate to great improvements on the PGIC. Over the 12 weeks, significant improvements were not shown in symptoms (Table 2), however, 50% of participants had improvements from baseline in sleep disturbance and 44% had improvements in anxiety, pain interference, and fatigue. A significant improvement was found in perceived self-efficacy in medications management (p = 0.01). Although perceived informational support increased, results did not reach statistical significance (p = 0.08). 95% of people (18/19) felt the program helped them stay positive; 89% said it improved their mood. Participants reported that health coaching was important to them and 63% said talking to someone with their condition was what they liked best.

Conclusion: A 12-week program addressing SSc symptom management with peer health coaches was feasible to deliver and was positively viewed by patients. Health coaching by trained peers was particularly valuable to patients.


Disclosures: S. Murphy, None; Y. Chen, None; M. Alore, None; S. Hicks, None; D. Khanna, AbbVie, 2, Acceleron, 2, Actelion, 2, Amgen, 2, Bayer, 2, 5, Boehringer Ingelheim, 2, Bristol-Myers Squibb, 5, CiviBioPharma/Eicos Sciences, Inc, 12, Leadership/Equity position (Chief Medical Officer), Corbus, 2, CSL Behring, 2, Eicos Sciences, Inc, 11, Galapagos NV, 2, Genentech/Roche, 2, Gilead, 2, GlaxoSmithKline, 2, Horizon Therapeutics, 2, 5, Immune Tolerance Network, 5, Merck Sharp & Dohme, 2, Mitsubishi Tanabe Pharma, 2, National Institutes of Health, 5, Pfizer, 5, Sanofi-Aventis, 2, United Therapeutics, 2, Prometheus, 2, Theraly, 2, AstraZeneca, 2.

To cite this abstract in AMA style:

Murphy S, Chen Y, Alore M, Hicks S, Khanna D. Symptom Management in Systemic Sclerosis: A Pilot Study of a Web-based Intervention Using Peer-Health Coaches [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/symptom-management-in-systemic-sclerosis-a-pilot-study-of-a-web-based-intervention-using-peer-health-coaches/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/symptom-management-in-systemic-sclerosis-a-pilot-study-of-a-web-based-intervention-using-peer-health-coaches/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology